← Leaderboards
Paul A. Watkins
Hugo W. Moser Res Inst Kennedy Krieger
$4,502,851
Attributed
$4,502,851
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $352.2K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,502,851 · 6
By mechanism
R01$3,958,314 · 2
R21$444,537 · 1
R03$80,000 · 1
R13$20,000 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- S. Ali Fatemi$6,844,676
- George H Thomas$679,169
- Michael Van Doren Johnston$16,567,736
- Kirby D Smith$0
- Paul A Watkins$502,191
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeFatty Acid MetabolismAdrenoleukodystrophyLaboratory MouseLipidsAcyl CoaDisease /Disorder ModelLong Chain Fatty AcidNovel Therapeutic InterventionFatty Acid SynthaseAffectBaseCell LineAdultChildhoodSex Linked TraitPublic Health RelevanceHuman Genetic Material TagPeroxisomeEnzyme ActivityFatty AcidsBehaviorCellsAutophagocytosis
Grant awards (17)
Drug Discovery for X-Linked Adrenoleukodystrophy$202,070
R21 · FY2016 · NS · contact PI
Drug Discovery for X-Linked Adrenoleukodystrophy$242,467
R21 · FY2015 · NS · contact PI
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular$333,064
R01 · FY2013 · NS · contact PI
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular$345,144
R01 · FY2012 · NS · contact PI
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular$345,144
R01 · FY2011 · NS · contact PI
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular$348,666
R01 · FY2010 · NS · contact PI
Acyl-CoA synthetase ACSVL3 in Malignant Glioma: Metabolism and Oncogenic Cellular$352,188
R01 · FY2009 · NS · contact PI
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases$333,963
R01 · FY2006 · NS · contact PI
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases$342,000
R01 · FY2005 · NS
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases$342,000
R01 · FY2004 · NS
Brain Uptake and Utilization of Fatty Acids and Lipids$20,000
R13 · FY2004 · NS
XALD: Role of Very Long Chain Fatty Acyl-CoA Synthetases$365,750
R01 · FY2003 · NS
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES$291,883
R01 · FY2002 · NS
DHA SYNTHESIS AND TRANSPORT IN PEX2-/-MOUSE$80,000
R03 · FY2002 · HD
ENZYMATIC REGULATION OF VERY LONG CHAIN FATTY ACID$0
P01 · FY2002 · HD
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES$283,384
R01 · FY2001 · NS
XALD--ROLE OF VERY LONG CHAIN FATTY ACYL COA SYNTHETASES$275,128
R01 · FY2000 · NS